epilepsy society research centre
Our brand new research centre in Chalfont St Peter, Buckinghamshire, is enabling us to carry out the most advanced epilepsy research in Europe and translate it into clinical practice. The state-of-the-art two-storey building has been made possible by the generosity of charitable trusts and donors who like us are dedicated to pushing forward the boundaries of research into epilepsy.
The centre integrates research with our medical unit, magnetic resonance imaging (MRI) suite and therapeutic drug monitoring unit. It offers a spacious laboratory, four new consulting rooms, offices, a library, seminar room and video conferencing facilities. But above all it offers new hope for people with epilepsy.
One of the greatest challenges facing us today is our lack of knowledge about the underlying causes of epilepsy. Advanced scanning techniques enable us to see the effects of seizures on a person’s brain. But we still cannot explain how one single seizure happens – what is that final event that causes excess electrical activity in the brain to generate a seizure.
For 70 per cent of people with epilepsy, anti-epileptic drugs can control their seizures but a further 30 per cent do not respond to medication.
Our research focuses on two distinct areas: brain imaging and genetics. But one of the most significant innovations at Epilepsy Society Research Centre is the installation of our DNA sequencer. This has the potential to revolutionise the way we diagnose and treat epilepsy based on a person’s DNA sequence or genome. It is our passport to the future and our gateway to earlier diagnosis and more targeted treatments.
Our vision is to unravel the complex genetic architecture of the epilepsies and to take new discoveries directly to patient care, so improving the lives of everyone with epilepsy. Epilepsy Society Research Centre is key to this vision.
Find out more about our research projects taking place at the research centre.
switchboard 01494 601 300